CypD: The Key to the Death Door

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|14|5|654-663

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.5, 2015-06, pp. : 654-663

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Specific Inhibitors of CYP707A, a Key Enzyme in the Catabolism of Abscisic Acid

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3230-3244

Bentham Science Publishers

Access to resources Recommend Favorite

Implementation of CYP2D6 genotyping in psychiatry

By Loovers Harriët M   van der Weide Jan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6 and the severity of suicide attempts

By Peñas-Lledó Eva M   Blasco-Fontecilla Hilario   Dorado Pedro   Vaquero-Lorenzo Concepción   Baca-García Enrique   Llerena Adrián  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 179-184

Future Medicine

Access to resources Recommend Favorite

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

By Skierka Jennifer M   Walker Denise L   Peterson Sandra E   O’Kane Dennis J   Black John Logan  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite

In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6

By Weiss Johanna  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Iss. 3, 2008-09 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite